Why Do New Therapies Succeed Or Fail In The Marketplace?
How can decisions made during the preclinical phase of drug development increase the chances of a product’s eventual success in a difficult marketplace?
Better Treatments By Design
To be successful, new treatments require real-world outcomes for you, your stakeholders, and most importantly the patients.
Particle Size Reduction
Characterization of the micronized drug is important to understand its bulk properties and design downstream processes and manufacturing approaches.
Better Treatments by Design™
Optimal dose development and manufacturing.
Catalent Spray Drying Technology
A holistic approach to the development and manufacture spray dried dispersions.
Considering Patient’s Voice in Drug Design
Strategies on incorporating patient opinion into early drug design and boost patient adherence.
Patient-centric Dose Design
Avoid some of the limitations of conventional tablet dose forms & more.
The Medicine Maker – Finding Optimal Form
Increase chances of success in drug development by focusing on API optimization from the start.
Softgel Capsules Low Batch Size Optimize in cGMP Labs
Handle small amounts of API or formulation at the early stages of development.
Optimization of Type I & II Lipid Based Drug Delivery System
Limit individual variability of type I & II systems with adequate choice of composition.
The Versatility of Softgel Technology
Optimize manufacturing parameters like lower processing temperature & thinner softgel shell.
Lipid-Based Delivery of Peptide Therapeutics
An explanation of OptiGel Bio™ technology as a delivery tool for macromolecule NCE candidates.
Conversion from LFHS to RP Scherer Softgel Capsules
RP Scherer Technology can improve timelines and commercialization potential.